Northern Sun to Begin Trading on the TSX Venture Exchange on April 15, 2014
Marketwire - Tue Apr 15, 3:01PM CDT
Northern Sun Mining Corp. (formerly Liberty Mines Inc.)(TSX: NSC) announces that its common shares have been approved for listing on the TSX Venture Exchange. The common shares of Northern Sun will be delisted from the Toronto Stock Exchange at the close of business on Tuesday, April 15, 2014 and will commence trading on the TSX Venture Exchange at the open of business on Wednesday, April 16, 2014 under the ticker symbol NSC.
QMX Reports Revenue of $30.62 Million and Operational Cash Flow of $5.45 Million for 2013
Marketwire - Tue Apr 01, 7:04AM CDT
QMX GOLD CORPORATION (TSX VENTURE: QMX) ("QMX" or the "Company"
QMX Gold Produces Over 22,000 Ounces of Gold in 2013 from Lac Herbin Mine
Marketwire - Tue Feb 25, 6:04AM CST
QMX GOLD CORPORATION (TSX VENTURE: QMX) ("QMX Gold" or the "Company"
QMX to Begin Trading on TSX Venture Exchange on February 20, 2014
Marketwire - Tue Feb 18, 6:02AM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company"
QMX Continues Trading on the TSX Until February 24, 2014
Marketwire - Mon Feb 10, 6:01AM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company"
Best's Rating Notification - Mercury County Mutual Insurance Company
Rating Division - AMBest - Fri Jan 31, 10:34AM CST
A.M. Best Company has made the following rating update:
QMX Gold Extends Loan Facility With Third Eye Capital
Marketwire - Tue Jan 28, 4:31PM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company"
Global Orphan Drug Pipeline Analysis
M2 - Fri Jan 17, 3:54AM CST
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry. With close to 65-70 Million people in the US & Europe having some kind of rare disease complaints, the increasing activities around the development of orphan drugs only imply that the appropriate treatments for unmet needs are increasing, thus increasing the profit margins in the future. As the Asian pharmaceutical markets are still in growth stage, the opportunities for orphan drugs in Asia are also immense and getting increasingly popular. It is expected that by 2020, the Asian orphan drugs market would witness steady growth.
QMX Gold Agrees to Extend Closing on the Sale of Snow Lake Property
Marketwire - Wed Jan 15, 7:30AM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company"
QMX Confirms Application for Stock to Begin Trading on TSX Venture Post TSX Delisting
Marketwire - Wed Dec 11, 11:07AM CST
QMX GOLD CORPORATION (TSX: QMX) ("QMX Gold" or the "Company"